Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2022-07-05 00:00:00 ET · period of report 2022-06-30 · accession 0001209191-22-040789 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-05 | 2022-06-30 | YARW | Zeronda Tyler | CFO | F - Tax | $0.39 | -354 | 173.7K | -0.2% | -$138.06 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-30 | F | D | 354 | $0.39 | 173,712 | D | — | — | (F1) Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |